Search Results - "LANGMAN, Michael J"
-
1
Phase III Randomized Trial Assessing Rofecoxib in the Adjuvant Setting of Colorectal Cancer: Final Results of the VICTOR Trial
Published in Journal of clinical oncology (20-10-2010)“…Laboratory and case-control studies suggest a pivotal role for the cyclooxygenase-2 (COX-2) pathway in colorectal carcinogenesis. The purpose of this study was…”
Get full text
Journal Article -
2
Sudden death in patients receiving drugs tending to prolong the QT interval
Published in British journal of clinical pharmacology (01-11-2009)“…WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT • Drugs slowing electocardiographic QT conduction can cause tachyarrhythmias, torsades de pointes (TdP) and cardiac…”
Get full text
Journal Article -
3
Rofecoxib and Cardiovascular Adverse Events in Adjuvant Treatment of Colorectal Cancer
Published in The New England journal of medicine (26-07-2007)“…In this clinical trial, rofecoxib (25 mg per day) was studied in the prevention of recurrent colorectal cancer. Although the median duration of study treatment…”
Get full text
Journal Article -
4
Antihypertensive medication and the risk of acute pancreatitis: The European case-control study on drug-induced acute pancreatitis (EDIP)
Published in Scandinavian journal of gastroenterology (01-12-2006)“…Objective. Angiotensin-converting enzyme (ACE) inhibitors and diuretics have been associated with acute pancreatitis. We quantified the risk of acute…”
Get full text
Journal Article -
5
Adverse effects of conventional non-steroidal anti-inflammatory drugs on the upper gastrointestinal tract
Published in Fundamental & clinical pharmacology (01-08-2003)“…This article reviews the clinical and epidemiological features of conventional non‐steroidal anti‐inflammatory drug (NSAID) related peptic ulcer complications,…”
Get full text
Journal Article -
6
Adverse Upper Gastrointestinal Effects of Rofecoxib Compared With NSAIDs
Published in JAMA : the journal of the American Medical Association (24-11-1999)“…CONTEXT Nonsteroidal anti-inflammatory drug (NSAID)–induced gastrointestinal (GI) toxic effects, such as upper GI tract perforations, symptomatic…”
Get full text
Journal Article -
7
Psychotropic medication: curing illness or creating problems?
Published in Heart (British Cardiac Society) (01-12-2009)Get more information
Journal Article -
8
Is Thiosulfate Sulfurtransferase the Colonic Sulfide Oxidase?
Published in Digestive diseases and sciences (01-03-2008)Get full text
Journal Article -
9
NSAIDs and gastrointestinal cancer prevention
Published in Drugs (New York, N.Y.) (2002)“…Numerous studies report the relationship between aspirin and other nonsteroidal anti-inflammatories (NSAIDs) and cancer incidence, in particular for colorectal…”
Get full text
Journal Article -
10
Loss of Estrogen Inactivation in Colonic Cancer
Published in The journal of clinical endocrinology and metabolism (01-06-1999)“…Age and sex differences in the incidence of colonic cancer, together with epidemiological data on patients taking hormone replacement therapy, suggest the…”
Get full text
Journal Article -
11
Controversies in COX-2 selective inhibition
Published in Journal of rheumatology (01-07-2002)Get full text
Journal Article -
12
Heparin therapy for ulcerative colitis? Effects and mechanisms
Published in European journal of gastroenterology & hepatology (01-04-2001)“…Despite intensive medical treatment with steroids and immunosuppressants, acute colitis is still associated with a colectomy rate of up to 15%. Following the…”
Get full text
Journal Article -
13
Rofecoxib and the Risk of Adverse Upper Gastrointestinal Effects—Reply
Published in JAMA : the journal of the American Medical Association (19-04-2000)Get full text
Journal Article -
14
Targets of 17β-oestradiol-induced apoptosis in colon cancer cells: a mechanism for the protective effects of hormone replacement therapy?
Published in Journal of endocrinology (01-05-2004)Get full text
Journal Article -
15
Protein kinase C delta is not activated by caspase-3 and its inhibition is sufficient to induce apoptosis in the colon cancer line, COLO 205
Published in Cellular signalling (01-02-2005)“…Activation of protein kinase C δ (PKCδ) is believed to be pro-apoptotic. PKCδ is reported to be reduced in colon cancers. Using a colon cancer cell line, COLO…”
Get full text
Journal Article -
16
Smoking And Ulcerative Colitis [With Reply]
Published in British medical journal (Clinical research ed.) (28-04-1984)Get full text
Journal Article -
17
-
18
Protein kinase C inhibition induces DNA fragmentation in COLO 205 cells which is blocked by cysteine protease inhibition but not mediated through caspase-3
Published in Experimental cell research (10-09-2003)“…Enhancing apoptosis to remove abnormal cells has potential in reversing cancerous processes. Caspase-3 activation generally accompanies apoptosis and its…”
Get full text
Journal Article -
19
Targets of 17beta-oestradiol-induced apoptosis in colon cancer cells: a mechanism for the protective effects of hormone replacement therapy?
Published in Journal of endocrinology (01-05-2004)“…Epidemiological studies show a strong link between postmenopausal hormone replacement therapy and decreased incidence of colorectal cancer. The colon cancer…”
Get full text
Journal Article -
20
Apoptosis is induced by 17b-estradiol in COLO 205 cells — possible role of ERB
Published in Gastroenterology (New York, N.Y. 1943) (01-04-2000)Get full text
Journal Article